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ORIGINAL ARTICLE
Blood Pressure Lowering and Vasomodulator
Effects of Piperine
Syed Intasar Husain Taqvi, PhD,*† Abdul Jabbar Shah, PhD,†‡ and
Anwarul Hassan Gilani, PhD†
Abstract: This study was aimed to explore underlying mechanism(s)
of cardiovascular effects of piperine. Intravenous administration of
piperine caused a dose-dependent (1 to 10 mg/kg) decrease in mean
arterial pressure (MAP) in normotensive anesthetized rats; the next
higher dose (30 mg/kg) did not cause any further change in MAP. The
fall in blood pressure (BP) was followed by small increase in MAP
after each dose. In Langendorrf’s rabbit heart preparation, piperine
caused partial inhibition and verapamil caused complete inhibition of
force and rate of ventricular contractions and coronary flow. In rabbit
aortic rings, piperine inhibited high K+ (80 mM) precontractions
and partially inhibited phenylephrine (PE), suggesting Ca2+ channel
blockade (CCB), which was further confirmed when pretreatment of
tissues with piperine caused rightward shift in Ca2+ concentration-
response curves, similar to verapamil. In Ca2+-free medium, piperine
(1 to 30 mM) exhibited vasoconstrictor effect. In rat aorta, piperine
demonstrated endothelium-independent vasodilator effect and was
more potent against high K+ precontractions than PE. In bovine
coronary artery preparations, piperine inhibited high K+ precon-
tractions completely. These data indicate that piperine possesses
a blood pressure–lowering effect mediated possibly through CCB,
while consistent decrease in BP was restricted by associated
vasoconstrictor effect. Additionally, species selectivity exists in the
CCB effect of piperine.
Key Words: piperine, antihypertensive, vasorelaxation, calcium
antagonist, vasoconstriction, vasomodulator
(J Cardiovasc Pharmacol TM 2008;52:452–458)
INTRODUCTION
Piperine is a pungent alkaloid isolated from Piper
longum L. and Piper nigrum L. species, which contain
piperidine ring (Figure 1)1. Piperine has not been studied
extensively for its cardiovascular effects, except for a few
preliminary reports. A mixture of piperine and piperdardine
showed antihypertensive effect in rat2 without describing the
underlying mechanism(s). Piperine has been found without
direct effect on the heart, although it exhibited positive
chronotropic and inotropic effects mediated through the
release of calcitonin gene–related peptide from nonadrenergic
and noncholinergic nerves in isolated rat atria.3 Additionally,
piperine also possesses antiplatelet,4 antipyretic and analge-
sic,5 antiinflammatory,6 and antidepressant7 characteristics.
Piperine also exhibits a contractile effect in urinary bladder,
which is mediated through transient receptor potential
vanilloid 1 (TRPV1).8 Apart from these cardiovascular effects,
many diverse biological activities of piperine have been
comprehensively reviewed recently.9
Our previous studies show that piperidine derivatives
perform direct action on cardiac muscle, exhibiting a cardio-
depressant effect mediated through calcium channel block-
ade.10,11 Our recent study12 demonstrates that piperine
mediates spasmolytic effect through calcium antagonism.
On the basis of these observations and the heterogeneous
nature of calcium channels,13 we studied the effect of piperine
on blood pressure and demonstrated that it lowers blood
pressure at lower doses; at higher doses, the decrease in blood
pressure is accompanied by vasoconstrictor effect.
MATERIALS AND METHODS
Drugs and Standards
The following reference chemicals were obtained from
the sources specified: acetylcholine chloride, atropine sulfate,
Nv-nitro-L-arginine methyl ester hydrochloride (L-NAME),
norepinephrine hydrochloride, phenylephrine hydrochloride,
verapamil hydrochloride and ethyleneglycoltetraacetic acid
(EGTA) (Sigma Chemical Company, St. Louis, MO), piperine
(Sigma-Aldrich Cemie GmbH, Germany), and Tween80
(Chemie S.S., La Jota, Barcleona, Spain). Heparin injections
were purchased from Rotex Medica (Trittau, Germany), and
pentothal sodium was obtained from Abbott Laboratories,
Pakistan. All chemicals used were of the highest purity grade.
Stock solutions were made in saline, whereas piperine was
dissolved in Tween80; the dilutions were made fresh on the
day of experiment.
Animals
Experiments performed complied with the rulings of the
Institute of Laboratory Animal Resources, Commission on
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Life Sciences, National Research Council14 and were approved
by the Ethical Committee of Aga Khan University, Karachi.
Sprague-Dawley (SD) male rats (200 to 250 g) and local male
rabbits (1.5 to 2 kg) were housed in the animal house of Aga
Khan University under controlled environment (23 to 25oC).
Animals were fed standard diet consisting of (in g/kg): flour
380, choker 380, molasses 12, salt 5.8, nutrivetL 2.5,
potassium metabisulphate 1.2, vegetable oil 38, fish meal
170, and powdered milk 150 and were given tap water ad
libitum.
The bovine hearts were collected freshly from a local
slaughter house and placed in normal Krebs solution.
Coronary vessel was isolated and extravascular tissues were
trimmed off in the laboratory.
Measurement of Blood Pressure in
Normotensive Anesthetized Rats
These experiments were performed on SD male rats
(200 to 250 g) as described previously.15 Animals were
anesthetized with an i.p injection of sodium thiopental
(Pentothal, 90 to 100 mg/kg) and were fixed in a supine
position on a dissecting table, a small mid-tracheal incision
(approximately 1 cm) was made to expose trachea, right
jugular vein, and left carotid artery. The trachea was
cannulated with a polyethylene tubing PE-20 and cleaned
from time to time to maintain the spontaneous respiration. The
right jugular vein was cannulated with a polyethylene tubing
PE-50 to facilitate the intravenous administration of the
standard drugs and test compounds. The carotid artery was
cannulated with the similar tubing filled with heparinized
(60 IU/mL) saline to prevent clotting of blood and connected
to a pressure transducer with cable kit (MLT 1199) coupled
with Power Lab data acquisition system (ADInstruments,
Sydney, Australia). This connection was used for blood
pressure recording. The exposed surface for the cannulation
was covered with a piece of tissue paper moistened in warm
saline. Body temperature of the animal was maintained by
using an overhead lamp.
Animals were allowed to equilibrate for at least
20 minutes before the administration of any drug or test
compound. Control responses of standards, such as acetyl-
choline (ACh, 1 mg/kg) and norepinephrine (NE, 1 mg/kg)
were obtained before the testing of piperine. A change in mean
arterial pressure (MAP) was recognized as the difference
between the steady-state value before and the lowest reading
after injection. The MAP was determined from the sum of
diastolic blood pressure plus1/3 pulse width. Changes in MAP
were expressed as percent of control values obtained imme-
diately before the administration of test substance. The blood
pressure was allowed to return to normal before the next dose
was added, and the doses mentioned in the text represent the
actual dose added each time.
Langendorrf’s Isolated Rabbit Heart
The nonworking whole heart of male rabbit16 was used,
and the protocol was followed as described earlier.10,11 As per
protocol, heparin (60 IU/kg) was injected (i.p) 1 hour before
isolation of heart, euthanized by cervical dislocation. Heart
was excised rapidly and cannulated at the base of the aortic
arch and mounted on Langendorrf’s apparatus as quickly as
possible; heart was perfused in a retrograde fashion, with
Krebs-Henseliet solution at constant flow of 12 to 18 mL/min,
and aerated with 5% CO2 in O2 (Carbogen) of thermostatically
controlled temperature at 37C with pH of 7.4. The composi-
tion of Krebs-Henseliet solution was (in mM): NaCl 117, KCl
1.41, MgSO47 H2O 1.2, KH2PO4 1.1, glucose 5.0, NaHCO3
2.5, and CaCl2 2.5. A ventricular hook was placed through the
apex of the spontaneously beating ventricle and connected
via a pulley to a force transducer (model FT-03). Ventricular
activity was transmitted by Harvard isotonic transducers and
recorded through Student Oscillograph. Heart showing any
abnormal rhythm was discarded.
Rabbit Aorta
As described previously,15 rats were killed by cervical
dislocation, and the descending thoracic aorta was isolated and
cut into 2 to 3 mm wide rings; each ring was mounted in a
5 mL tissue bath containing normal Krebs solution maintained
at 37C and aerated with carbogen. The composition of normal
Krebs solution was (in mM): NaCl 118.2, KCl 4.7, NaHCO3
25.0, CaCl2 2.5, KH2PO4 1.3, MgSO4 1.2, and glucose 11.7
(pH 7.4). A resting tension of 2 g was applied to each tissue,
and an equilibrium period of 1 hour was allowed before
experimentation. Changes in tension were recorded by World
Precision Instrument (WPI) through isometric force trans-
ducers (Fort-100) connected to Transbridge 4M and displayed
on a computer via Power Lab (ML845) data acquisition system
(ADInstruments, Sydney, Australia).
After 1 hour equilibrium period, tissues were stabilized
by fixed concentration of phenylephrine (PE, 1 mM). The
tissues were considered stable only when similar responses were
displayed after repeated application of PE (1 mM). Effect of
the piperine or verapamil was first determined on the resting
baseline of the tissue for possible vasoconstrictor effect. The
effect of test compound and standard drugs were later tested
against the agonists; PE (1 mM) and high K+ (80 mM) induced
contractions. The ability of the test compound to relax
high K+-induced contractions possibly indicates a voltage-
dependent calcium channel blocking (CCB) effect; whereas
inhibition of the PE-induced contractions is indicative of the
blockade of Ca2+ influx through receptor-operated calcium
channels (ROCCs) or Ca2+ release from the internal store(s).17
To confirm the CCB activity, Ca2+ concentration-response
curves (CRC) were constructed in Ca2+-free medium. Then the
effect of the increasing concentrations of the test compound
was determined on the Ca2+ CRCs. The rightward shift in the
Ca2+ CRCs was considered to possess CCB activity.
To determine if the test compound was inhibiting the
Ca2+ release from intracellular stores, the effect of increasing
FIGURE 1. Structure of piperine.
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concentrations of the test compound was tested against the PE
(1 mM) initial peak formation in Ca2+-free medium. The
composition of Ca2+-free Krebs solution was prepared by
omitting CaCl2 from the normal Krebs with addition of EGTA
(0.1 mM) to ensure total elimination of extracellular Ca2+.18
Changes in isometric tensions of the rings were measured
through a force transducer (Fort-100, WPI, UK) coupled with
bridge amplifier (Transbridge TBM4) and Power Lab (ML845)
data acquisition system (ADInstruments, Sydney, Australia).
Rat Aorta
The procedure of Furchgott and Zawadski19 was
followed with some modifications; descending thoracic aorta
was isolated from male rats, and care was observed to avoid
damage to the endothelium. Approximately 3 mm wide rings
were mounted in a 5 mL tissue bath containing normal Krebs
solution, maintained at 37oC, and aerated with carbogen.
A preload of 1 g was applied to each preparation and allowed
to incubate for 30 minutes before exposure to any compound.
After the equilibrium period of 30 minutes, the tissue was
stabilized with repeated concentrations of PE (1 mM). The
integrity of endothelium was confirmed by the ability of the
tissues to produce relaxation to ACh (0.1 mM). The
endothelium lining of the tissues was removed by gentle
rubbing with forceps, which resulted in the disappearance of
this relaxation to ACh. To see whether the vasodilator effect of
the test compound is endothelium-dependent, the effect of the
compound was repeated in the presence of L-NAME (0.1 mM)
and in denuded aortic rings.20,21
Bovine Left Descending Coronary Artery
The protocol of Campbell et al22 was followed with
some modifications; fresh bovine hearts were collected from
a local slaughterhouse, and left descending coronary artery
were dissected and cleaned of connective tissue in normal
Krebs solution. The artery was cut into 2- to 3-mm diameter
rings, mounted in 5-mL tissue baths containing normal Krebs
solution, maintained at 37C, and aerated with carbogen.
Vessels were equilibrated for 1.5 hours under 2 g of resting
tension. High K+ (40 mM) was added to the bath until
reproducible maximal contractions were obtained. Tension
was recorded and analyzed through a force transducer (Fort-
100, WPI, UK), coupled with bridge amplifier (Transbridge
TBM4) and Power Lab (ML 845) data acquisition system
(ADInstruments, Sydney, Australia).
Statistical Analysis
Data expressed are mean 6 standard error (SEM, n =
number of experiments) and the median effective concentra-
tion (EC50 values) with 95% confidence intervals (CI). The
statistical parameter applied is the Student t test with P, 0.05
as significantly different. Concentration response curves were
analyzed by nonlinear regression using GraphPAD graphing
software version 4 (GraphPAD, San Diego, CA).
RESULTS
Effect on Blood Pressure in Normotensive
Anesthetized Rat
Intravenous administration of piperine caused a dose-
dependant decrease in MAP at 1 to 10 mg/kg in normotensive
anesthetized rats; next dose of 30 mg/kg did not produce
further decline in MAP, whereas additional increase in dose
(100 mg/kg) caused little decline in BP, suggesting the
involvement of some vasoconstricting mechanism(s) at higher
doses. The fall in BP was followed by a slight increase in BP
after each dose and a return to normal within a few minutes
(Figure 2A). The percent declines in MAP at the respective
doses of 1, 3, 10, 30, and 100 mg/kg were 9.34 6 5.45,
22.37 6 5.42, 30.34 6 4.40, 34.62 6 4.31, and 20.33 6 1.45
mmHg, respectively (Figure 2B). Whereas under similar
experimental conditions, verapamil caused dose-dependent
decrease in MAP, with percent declines of 4.57 6 2.10,
13.93 6 1.73, 30.40 6 1.61, 40.10 6 5.60, and 55.20 6 2.71
mmHg at respective doses (Figure 2C).
Effect on Langendorrf’s Isolated Rabbit Heart
When piperine was tested in isolated rabbit heart
mounted in the Langendorrf’s apparatus, piperine (0.01 to
10 mM) induced partial inhibition with maximum effect
around 70% on the force and rate of ventricular contractions
and coronary flow (Figure 3A) with respective EC50 values of
2.65 (95% CI, 1.38 to 5.06), 5.29 (95% CI, 2.67 to 10.49), and
1.16 mM (95% CI, 0.56 to 2.44). Under similar experimental
conditions, verapamil caused complete inhibition of the force,
rate, and coronary flow (Figure 3B), with respective EC50
values of 1.18 (95% CI, 0.72 to 1.91), 0.42 (95% CI, 0.22 to
0.78), and 3.22 mM (95% CI, 1.93 to 5.37).
Effect on Rabbit Aorta
When tested in isolated rabbit aortic preparations against
contractions induced by high K+, cumulative addition of
piperine caused complete relaxation with EC50 values of 30.93
mM (95% CI, 14.80 to 64.65); it partially relaxed the PE
precontractions (Figure 4A), and verapamil caused complete
inhibition of high K+ and PE precontractions with respective
EC50 values of 0.10 (95% CI, 0.05 to 0.18) and 0.12 mM (95%
CI, 0.07 to 0.25) (Figure 4B). Pretreatment of aortic rings with
piperine (30 to 100 mM) induced concentration-dependent
rightward shift in the Ca2+ CRCs, constructed in Ca2+-free
medium (Figure 4C) similar to that caused by verapamil
(Figure 4D). When tested on baseline tension in Ca2+-free
medium, cumulative addition of piperine caused contractile
effect (Figure 4A). However, in aortic rings incubated in Ca2+-
free medium, piperine pretreatment had no inhibitory effect on
the initial PE peaks formation (data not shown).
Effect on Rat Aorta
When tested in isolated rat aorta preparations, cumu-
lative addition of piperine induced endothelium-independent
relaxation (Figure 5A), similar to verapamil (Figure 5B). The
respective EC50 values of piperine in the intact and denuded
endothelium aortic rings were 25.09 (95% CI, 19.69 to 31.96)
and 23.67 mM (95% CI, 13.30 to 42.12). Piperine also
454 q 2008 Lippincott Williams & Wilkins
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inhibited high K+-induced contractions, with EC50 value of
2.52 mM (95% CI, 1.78 to 3.58) (Figure 5A). When piperine
was tested on baseline resting tension in normal Krebs
solution, piperine was found to be without contractile effect,
similar to verapamil.
Effect on Bovine Coronary Artery
In isolated bovine coronary arterial rings, cumulative
addition of piperine and verapamil caused inhibition of
contractions induced by high K+, with respective EC50 values
of 7.5 (95% CI, 5.70 to 9.84) and 0.12 mM (95% CI, 0.08 to
0.16) (Figure 6). When piperine was tested on baseline resting
tension in normal Krebs solution, piperine was found devoid
of contractile effect.
DISCUSSION
In view of the potential calcium channel blocking effect
of compounds containing piperidine,10–12 we assessed piperine
for its possible antihypertensive effect and subsequently for
vascular reactivity. When tested in anesthetized normotensive
rats, intravenous administration of piperine caused a dose-
dependent (1 to 10 mg/kg) fall in MAP. At the next higher dose
(30 mg/kg), the effect was similar to the previous dose (P .
0.05), whereas the BP-lowering effect declined with next
higher dose. Moreover, at each dose of piperine, BP decrease
was followed by a small increase in the response that returned
to normal. These data suggest that piperine possesses a BP-
lowering effect along with some vasoconstricting mecha-
nism(s) that dose-dependently restrict further decreases in BP,
whereas verapamil caused consistent dose-dependent decrease
in BP. BP is the product of cardiac output and vascular
resistance,23 we studied the underlying mechanism(s) of
piperine on BP in isolated cardiovascular preparations. In
nonworking isolated rabbit heart, piperine attenuated (70%)
the force and rate of ventricular contractions and coronary flow
at lower concentrations, whereas the next higher concentration
was without further increase in response. Hence the results of
in vivo and in vitro experiments are showing partial inhibitory
effect of piperine.
The partial inhibitory effect of piperine suggests the
involvement of some interfering mechanism that opposes the
complete inhibition of all the observed variables, whereas
verapamil caused complete inhibition of all the observed
variables and finally blocked the working of the heart.
Furthermore, the data of Langendorrf’s heart indicate the
direct effect of piperine on the myocardium because the
autonomic reflexes are absent in the Langendorrf’s prepara-
tions, which could confound in intact animal.24 Moreover,
piperine is found to be different from verapamil, with CCB
being partially effective on the force, rate, and coronary flow
without causing cardiac arrest, whereas verapamil is clinically
known to cause AV blockade and complete heart arrest.25
Calcium channel antagonists are known to cause AV block and
cardiac slowing with negative inotropic effect, which results
from the inhibition of the slow inward Ca2+ current during the
action potential plateau.25 The negative inotropic and
chronotropic effects of piperine may be the outcome of
calcium channel blockade in the cardiac muscle, but its
FIGURE 2. A representative tracing showing the effect of
piperine (2A) on BP in normotensive anesthetized rats. Bar
graph depicts the hypotensive effect of piperine (2B) and
verapamil (2C) in normotensive anesthetized rats. Values
shown are mean 6 SEM of 5 determinations.
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inability to cause cardiac arrest is indicating some additional
mechanism, possibly interfering with inhibitory response
beyond certain limit, and this property may offer some
therapeutic merit, particularly when the cardiac suppression of
calcium channel blockers such as verapamil is also considered
as a side effect when used in a weak heart or when combined
with other cardiosuppressants, such as beta adrenoceptor
blockers. As a result, further experiments explored the possible
CCB effect of piperine in vascular preparations to characterize
the interfering mechanism that restricted the consistent
decrease in BP.
Vascular resistance is an important determinant of BP23;
therefore, 3 different vascular preparations were selected
(rabbit aorta, rat aorta, and bovine left descending coronary
FIGURE 3. Effects of piperine (A) and
verapamil (B) on force and rate of
ventricular contraction and coronary
flow in nonworking isolated rabbit
heart in Langendorrf’s experiments.
Values shown are mean 6 SEM
of 5 determinations.
FIGURE 4. Upper panel shows the
concentration-dependent inhibitory
effect of piperine (A) and verapamil
(B) on contractions induced by
phenylephrine (PE) and high K+
and on the baseline tension in
Ca2+-free medium in rabbit aorta.
Lower panel shows the effects of
piperine (4C) and verapamil (4D) on
the Ca2+ concentration-response
curves constructed in Ca2+-free
medium in isolated rabbit aorta prep-
arations. Values shown are mean 6
SEM of 3 determinations.
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artery) to understand the underlying mechanism(s) of the BP-
lowering effect of piperine and possible species selectivity.
Rabbit aorta was chosen to evaluate the effects of piperine on
contractions induced by high K+ and PE (1 mM) and to
distinguish between the effect on voltage-dependent calcium
channels (VDCs) and receptor-operated calcium channels
(ROCCs).26,27 When tested against the agonist-induced
contractions, piperine caused complete inhibition of high
K+-induced contractions, while it was found partially effective
against the PE, suggestive of the selective effect on VDCs.
Contraction of rabbit aortic preparations induced by high K+
depends on the influx of Ca2+ into the cells through VDCs,28
and a substance that can inhibit high K+-induced contractions
is, therefore, considered to be a CCB.29 Thus the inhibitory
effect of piperine against high K+ precontractions suggests the
presence of CCB effect. The CCB activity was further
confirmed when pretreatment of the aortic rings with piperine
shifted the Ca2+ CRCs to the right, constructed in Ca 2+-free
medium similar to verapamil, a standard CCB.30
Phenylephrine is known to cause aortic contraction by
increasing the intracellular Ca2+ concentration through the
release of Ca2+ from sarcoplasmic reticulum (SR) and influx
through ROCC.17 The partial inhibitory effect of piperine
against the PE precontractions suggests its inhibitory effect,
possibly mediated through inhibition of Ca2+ influx via ROCC,
which is possibly counteracted by simultaneous release of
Ca2+ from the Ca2+ store(s) under the influence of piperine. To
test this hypothesis, piperine was tested on basal tension in
Ca2+-free medium, where its cumulative addition caused
a concentration-dependent contractile effect reaching approx-
imately 75% of the PE (1 mM) control. These data suggest that
piperine causes the release of Ca2+ from the internal store; in
normal Krebs solution, piperine was found without contractile
effect, which may possibly explain the partial inhibitory effect
against the PE precontactions and further suggests vascular
modulator role of piperine mediated through Ca2+ movements.
This finding also provides substantial evidence to the dose-
dependent BP-lowering effect of piperine at lower doses,
which is probably due to the CCB effect. However, the
decrease in BP-lowering response at higher doses and increase
in BP after each dose is possibly due to the vasoconstrictive
effect, mediated through Ca2+ release, which may partly
explain the restricted decrease in BP and partial inhibitory
effect on the force, rate, and coronary flow observed in the
Langendorrf’s heart preparations.
The vascular endothelium plays a pivotal role in
modulating the vascular tone through the release of variety
of substances.20 In isolated rat aorta preparations, piperine
exhibited endothelium-independent inhibitory effect because
the effect was not different (P . 0.05) from that observed in
the denuded preparations and intact aortic rings incubated with
L-NAME. When tested against high K+ precontractions,
piperine was found to be approximately 11 times more potent
in rat than in rabbit aorta; similarly, piperine was without
contractile effect on baseline tension in rat aorta preparations
in Ca2+-free medium, indicating species selectivity.
The coronary artery of the heart is considered a major
therapeutic target of calcium antagonists.31,32 Therefore, CCB
activity of piperine was further tested against high K+
precontractions in isolated bovine coronary arterial
FIGURE 5. Endothelium-independent
inhibitory effects of piperine (A) and
verapamil (B) in isolated rat aorta
preparations. Values shown are
mean 6 SEM of 3 determinations.
FIGURE 6. Shows the effects of piperine and verapamil
against high K+ (40 mM) precontractions in bovine coro-
nary arterial preparations. Values shown are mean 6 SEM
of 3 determinations.
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preparations, wherein piperine produced relaxation of the
precontactions in concentration-dependent manner. Depola-
rizing stimuli elicit contractions in coronary artery, promoting
the entry of extracellular Ca2+ via membrane L-type Ca2+
channels.33 Therefore, relaxation induced by piperine against
high K+ precontracted bovine coronary arterial rings is likely
due to the blockade of Ca2+ influx through membrane L-type
Ca2+ channels similar to verapamil. Considering the pattern of
relaxation of high K+ precontracted vascular preparations,
piperine was found to be more potent in rat than rabbit and
bovine coronary arteries, indicating species selectivity. The
difference in the inhibitory activity of piperine in these
vascular preparations may also be due to the heterogeneous
nature of Ca2+ channels.13
In summary, these data indicate that piperine possesses
a CCB effect that is responsible for the cardiodepressant and
vasodilator activities that provide the pharmacological basis
for the BP-lowering effect, and the associated vasoconstrictor
effects provide substantial evidence to the restricted decrease
in BP and small increase in the BP followed by decline after
each dose. Piperine is distinct from verapamil, owing to the
presence of a vasoconstrictor effect possibly mediated through
Ca2+ release, which may offer therapeutic merit by not
allowing BP to decrease beyond a certain limit and which also
supports the general belief that food remedies are mild to
moderately effective with lesser side effects. Further electro-
physiological studies would provide more insight into the
molecular aspects of these mechanisms.
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